Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism

Atherosclerosis

Volumn 217, Issue 2, 2011, Pages 299-307

  Leiva, Andrea ^a   Verdejo, Hugo ^a   Benítez, María Luisa ^a   Martínez, Alvaro ^a   Busso, Dolores ^a   Rigotti, Attilio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Atherosclerosis; Bile; HDL; Hepatic SR BI expression; Reverse cholesterol transport; SR BI

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; ALPHA INTERFERON; ALPHA TOCOPHEROL; BILE ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL; ESTRADIOL; ETHINYLESTRADIOL; GLUCAGON; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 1; LEPTIN; LIOTHYRONINE; LIPOPOLYSACCHARIDE; OXYSTEROL; PHYTOSTANOL; POLYUNSATURATED FATTY ACID; PRATENSEIN; PROBUCOL; PROTEIN; PROTEIN PDZK1; SCAVENGER RECEPTOR BI; SOBETIROME; SOMATOMEDIN C; T 0681; THYROMIMETIC AGENT; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN;

ANTIATHEROGENIC EFFECT; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; DRUG EFFECT; DRUG TARGETING; HUMAN; LIPOPROTEIN METABOLISM; NONHUMAN; POSTTRANSCRIPTIONAL DOWN REGULATION; POSTTRANSCRIPTIONAL UPREGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD36; ATHEROSCLEROSIS; CHOLESTEROL, HDL; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; LIPOPROTEINS, HDL; LIVER; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION, GENETIC;

EID: 79960698521     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.05.036     Document Type: Review

References (120)

1. Krieger M., Kozarsky K. Influence of the HDL receptor SR-BI on atherosclerosis. Curr Opin Lipidol 1999, 10(6):491-497.
2. Rigotti A., Miettinen H.E., Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 2003, 24(3):357-387.
3. Trigatti B.L., Krieger M., Rigotti A. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23(10):1732-1738.
4. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232(4746):34-47.
5. Goldstein J.L., Brown M.S. The LDL receptor. Arterioscler Thromb Vasc Biol 2009, 29(4):431-438.
6. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271(5248):518-520.
7. Stein Y., Dabach Y., Hollander G., Halperin G., Stein O. Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether. Biochim Biophys Acta 1983, 752(1):98-105.
8. Glass C., Pittman R.C., Weinstein D.B., Steinberg D. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad Sci USA 1983, 80(17):5435-5439.
9. Silver D.L., Wang N., Tall A.R. Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J Clin Invest 2000, 105(2):151-159.
10. Silver D.L., Wang N., Xiao X., Tall A.R. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem 2001, 276(27):25287-25293.
11. Pagler T.A., Rhode S., Neuhofer A., et al. SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux. J Biol Chem 2006, 281(16):11193-11204.
12. Harder C.J., Vassiliou G., McBride H.M., McPherson R. Hepatic SR-BI-mediated cholesteryl ester selective uptake occurs with unaltered efficiency in the absence of cellular energy. J Lipid Res 2006, 47(3):492-503.
13. Ahras M., Naing T., McPherson R. Scavenger receptor class B type I localizes to a late endosomal compartment. J Lipid Res 2008, 49(7):1569-1576.
14. Zhang Y., Ahmed A.M., Tran T.L., et al. The inhibition of endocytosis affects HDL-lipid uptake mediated by the human scavenger receptor class B type I. Mol Membr Biol 2007, 24(5-6):442-454.
15. Rigotti A., Edelman E.R., Seifert P., et al. Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J Biol Chem 1996, 271(52):33545-33549.
16. Rigotti A., Trigatti B.L., Penman M., Rayburn H., Herz J., Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997, 94(23):12610-12615.
17. Mardones P., Quinones V., Amigo L., et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res 2001, 42(2):170-180.
18. Kozarsky K.F., Donahee M.H., Rigotti A., Iqbal S.N., Edelman E.R., Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997, 387(6631):414-417.
19. Wang N., Weng W., Breslow J.L., Tall A.R. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control. J Biol Chem 1996, 271(35):21001-21004.
20. Ueda Y., Royer L., Gong E., et al. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 1999, 274(11):7165-7171.
21. Ji Y., Wang N., Ramakrishnan R., et al. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 1999, 274(47):33398-33402.
22. Rinninger F., Brundert M., Brosch I., Donarski N., Budzinski R.M., Greten H. Lipoprotein lipase mediates an increase in selective uptake of HDL-associated cholesteryl esters by cells in culture independent of scavenger receptor BI. J Lipid Res 2001, 42(11):1740-1751.
23. Brundert M., Heeren J., Bahar-Bayansar M., Ewert A., Moore K.J., Rinninger F. Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI. J Lipid Res 2006, 47(11):2408-2421.
24. Brundert M., Ewert A., Heeren J., et al. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler Thromb Vasc Biol 2005, 25(1):143-148.
25. Braun A., Trigatti B.L., Post M.J., et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002, 90(3):270-276.
26. Huszar D., Varban M.L., Rinninger F., et al. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 2000, 20(4):1068-1073.
27. Kozarsky K.F., Donahee M.H., Glick J.M., Krieger M., Rader D.J. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000, 20(3):721-727.
28. Arai T., Wang N., Bezouevski M., Welch C., Tall A.R. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999, 274(4):2366-2371.
29. Ueda Y., Gong E., Royer L., Cooper P.N., Francone O.L., Rubin E.M. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 2000, 275(27):20368-20373.
30. Zhang Y., Da Silva J.R., Reilly M., Billheimer J.T., Rothblat G.H., Rader D.J. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 2005, 115(10):2870-2874.
31. Brunet R, How M, Trigatti BL. Modulators of protein kinase C affect SRBI-dependent HDL lipid uptake in transfected HepG2 cells. Cholesterol 2011: 687939. Epub 2011 Jan 5.
32. Nieland T.J., Penman M., Dori L., Krieger M., Kirchhausen T. Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc Natl Acad Sci USA 2002, 99(24):15422-15427.
33. Nieland T.J., Shaw J.T., Jaipuri F.A., et al. Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI. J Lipid Res 2007, 48(8):1832-1845.
34. Nishizawa T., Kitayama K., Wakabayashi K., et al. A novel compound R-138329, increases plasma HDL cholesterol via inhibition of scavenger receptor BI-mediated selective lipid uptake. Atherosclerosis 2007, 194(2):300-308.
35. Masson D., Koseki M., Ishibashi M., et al. Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor. Arterioscler Thromb Vasc Biol 2009, 29(12):2054-2060.
36. Lopez D., McLean M.P. Activation of the rat scavenger receptor class B type I gene by PPARalpha. Mol Cell Endocrinol 2006, 251(1-2):67-77.
37. Malerod L., Sporstol M., Juvet L.K., Mousavi A., Gjoen T., Berg T. Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha. Biochem Biophys Res Commun 2003, 305(3):557-565.
38. Malerod L., Juvet L.K., Hanssen-Bauer A., Eskild W., Berg T. Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem Biophys Res Commun 2002, 299(5):916-923.
39. Malerod L., Sporstol M., Juvet L.K., et al. Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1. Biochem Biophys Res Commun 2005, 336(4):1096-1105.
40. Lambert G., Amar M.J., Guo G., Brewer H.B., Gonzalez F.J., Sinal C.J. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem 2003, 278(4):2563-2570.
41. Schoonjans K., Annicotte J.S., Huby T., et al. Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Rep 2002, 3(12):1181-1187.
42. Sporstol M., Tapia G., Malerod L., Mousavi S.A., Berg T. Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I. Biochem Biophys Res Commun 2005, 331(4):1533-1541.
43. Gronemeyer H., Gustafsson J.A., Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 2004, 3(11):950-964.
44. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294(5548):1866-1870.
45. Fluiter K., van der Westhuijzen D.R., van Berkel T.J. In vivo regulation of scavenger receptor BI and the selective uptake of high density lipoprotein cholesteryl esters in rat liver parenchymal and Kupffer cells. J Biol Chem 1998, 273(14):8434-8438.
46. Landschulz K.T., Pathak R.K., Rigotti A., Krieger M., Hobbs H.H. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 1996, 98(4):984-995.
47. Lopez D., McLean M.P. Sterol regulatory element-binding protein-1a binds to cis elements in the promoter of the rat high density lipoprotein receptor SR-BI gene. Endocrinology 1999, 140(12):5669-5681.
48. Horton J.D., Shah N.A., Warrington J.A., et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA 2003, 100(21):12027-12032.
49. Lukic T., Wasan K.M., Zamfir D., Moghadasian M.H., Pritchard P.H. Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient mice. Metabolism 2003, 52(4):425-431.
50. Bao Y., Yang Y., Wang L., et al. Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells. Atherosclerosis 2009, 204(1):127-135.
51. Yang Y., Jiang W., Wang L., Zhang Z.B., Si S.Y., Hong B. Characterization of the isoflavone pratensein as a novel transcriptional up-regulator of scavenger receptor class B type I in HepG2 cells. Biol Pharm Bull 2009, 32(7):1289-1294.
52. Cao W.M., Murao K., Imachi H., et al. Insulin-like growth factor-i regulation of hepatic scavenger receptor class BI. Endocrinology 2004, 145(12):5540-5547.
53. Murao K., Yu X., Imachi H., et al. Hyperglycemia suppresses hepatic scavenger receptor class B type I expression. Am J Physiol 2008, 294(1):E78-87.
54. Buechler C., Ritter M., Quoc C.D., Agildere A., Schmitz G. Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages. Biochem Biophys Res Commun 1999, 262(1):251-254.
55. Lundasen T., Liao W., Angelin B., Rudling M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice. J Biol Chem 2003, 278(44):43224-43228.
56. Jeyakumar S.M., Vajreswari A., Giridharan N.V. Impact of vitamin A on high-density lipoprotein-cholesterol and scavenger receptor class BI in the obese rat. Obesity 2007, 15(2):322-329.
57. Straus D.S., Glass C.K. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 2007, 28(12):551-558.
58. Oliver W.R., Shenk J.L., Snaith M.R., et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 2001, 98(9):5306-5311.
59. Kersten, Kersten S. Peroxisome proliferator activated receptors and lipoprotein 835 metabolism. PPAR Res 2008:132960.
60. Cortes V., Quezada N., Rigotti A., Maiz A. New heterodimeric nuclear receptors: key metabolic regulators with relevance in the pathophysiology and therapy of dyslipidemias and diabetes mellitus. Rev Med Chile 2005, 133(12):1483-1492.
61. Spady D.K., Kearney D.M., Hobbs H.H. Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster. J Lipid Res 1999, 40(8):1384-1394.
62. Mardones P., Pilon A., Bouly M., et al. Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J Biol Chem 2003, 278(10):7884-7890.
63. Lan D., Silver D.L. Fenofibrate induces a novel degradation pathway for scavenger receptor B-I independent of PDZK1. J Biol Chem 2005, 280(24):23390-23396.
64. Fu T., Kozarsky K.F., Borensztajn J. Overexpression of SR-BI by adenoviral vector reverses the fibrateinduced hypercholesterolemia of apolipoprotein E-deficient mice. J Biol Chem 2003, 278(52):52559-52563.
65. Wojcicka G., Jamroz-Wisniewska A., Horoszewicz K., Beltowski J. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig Med Dosw 2007, 61:736-759.
66. Zhang Y, Yin L, Anderson J, Ma H, Gonzalez FJ, Willson TM, et al. Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia. J Biol Chem 2010; 285(5):3035-43.
67. Claudel T., Sturm E., Duez H., et al. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J Clin Invest 2002, 109(7):961-971.
68. Staudinger J.L., Goodwin B., Jones S.A., et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 2001, 98(6):3369-3374.
69. Blumberg B., Sabbagh W., Juguilon H., et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 1998, 12(20):3195-3205.
70. Sonoda J., Xie W., Rosenfeld J.M., Barwick J.L., Guzelian P.S., Evans R.M. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 2002, 99(21):13801-13806.
71. de Haan W., de Vries-van der Weij J., Mol I.M., et al. PXR agonism decreases plasma HDL levels in ApoE3-Leiden. CETP mice. Biochim Biophys Acta 2009, 1791(3):191-197.
72. Azzi A., Gysin R., Kempná P., et al. Vitamin E mediates cell signaling and regulation of gene expression. Ann NY Acad Sci 2004, 1031:86-89.
73. Serougne C., Feurgard C., Hajri T., et al. Catabolism of HDL1 cholesteryl ester in the rat. Effect of ethinyl estradiol treatment. Crit Res Acad Sci III 1999, 322(7):591-596.
74. Stangl H., Graf G.A., Yu L., Cao G., Wyne K. Effect of estrogen on scavenger receptor BI expression in the rat. J Endocrinol 2002, 175(3):663-672.
75. Miquel J.F., Moreno M., Amigo L., et al. Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium. Gut 2003, 52(7):1017-1024.
76. Niemeier A., Kovacs W.J., Strobl W., Stangl H. Atherogenic diet leads to posttranslational down-regulation of murine hepatocyte SR-BI expression. Atherosclerosis 2009, 202(1):169-175.
77. Clayton R.N. Cardiovascular function in acromegaly. Endocr Rev 2003, 24(3):272-277.
78. Khovidhunkit W., Moser A.H., Shigenaga J.K., Grunfeld C., Feingold K.R. Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines. J Lipid Res 2001, 42(10):1636-1644.
79. Murao K., Imachi H., Yu X., et al. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes. Gut 2008, 57(5):664-671.
80. Gruen M.L., Plummer M.R., Zhang W., et al. Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. J Lipid Res 2005, 46(9):2007-2014.
81. Perez-Tilve D., Hofmann S.M., Basford J., et al. Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci 2010, 13(7):877-882.
82. Jeyakumar S.M., Vajreswari A., Sesikeran B., Giridharan N.V. Vitamin A supplementation induces adipose tissue loss through apoptosis in lean but not in obese rats of the WNIN/Ob strain. J Mol Endocrinol 2005, 35(2):391-398.
83. Mendez-Gonzalez J., Suren-Castillo S., Calpe-Berdiel L., Rotllan N., Vazquez-Carrera M., Escola-Gil J.C., et al. Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice. Br J Nutr 2010, 103(2):153-160.
84. Bao Y., Yang Y., Wang L., et al. Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells. Atherosclerosis 2008.
85. Witt W., Kolleck I., Fechner H., Sinha P., Rustow B. Regulation by vitamin E of the scavenger receptor BI in rat liver and HepG2 cells. J Lipid Res 2000, 41(12):2009-2016.
86. Graf G.A., Roswell K.L., Smart E.J. 17beta-Estradiol promotes the up-regulation of SR-BII in HepG2 cells and in rat livers. J Lipid Res 2001, 42(9):1444-1449.
87. Johansson L., Rudling M., Scanlan T.S., et al. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc Natl Acad Sci USA 2005, 102(29):10297-10302.
88. Nakamura T., Shibata N., Nishimoto-Shibata T., et al. Regulation of SR-BI protein levels by phosphorylation of its associated protein, PDZK1. Proc Natl Acad Sci USA 2005, 102(38):13404-13409.
89. Shetty S., Eckhardt E.R., Post S.R., van der Westhuyzen D.R. Phosphatidylinositol-3-kinase regulates scavenger receptor class B type I subcellular localization and selective lipid uptake in hepatocytes. Arterioscler Thromb Vasc Biol 2006, 26(9):2125-2131.
90. Rinninger F., Wang N., Ramakrishnan R., Jiang X.C., Tall A.R. Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-I-dependent mechanism. Arterioscler Thromb Vasc Biol 1999, 19(5):1325-1332.
91. Webb N.R., Connell P.M., Graf G.A., et al. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem 1998, 273(24):15241-15248.
92. Zhang X., Moor A.N., Merkler K.A., Liu Q., McLean M.P. Regulation of alternative splicing of liver scavenger receptor class B gene by estrogen and the involved regulatory splicing factors. Endocrinology 2007, 148(11):5295-5304.
93. Zhang X., Merkler K.A., McLean M.P. Characterization of regulatory intronic and exonic sequences involved in alternative splicing of scavenger receptor class B gene. Biochem Biophys Res Commun 2008, 372(1):173-178.
94. Keaney J.F., Simon D.I., Freedman J.E. Vitamin E and vascular homeostasis: implications for atherosclerosis. Faseb J 1999, 13(9):965-975.
95. Berthou L., Duverger N., Emmanuel F., et al. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. J Clin Invest 1996, 97(11):2408-2416.
96. Duez H., Lefebvre B., Poulain P., et al. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation. Arterioscler Thromb Vasc Biol 2005, 25(3):585-591.
97. Tancevski I., Demetz E., Eller P., Duwensee K., Hoefer J., Heim C., et al. The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice. PLoS one 2010, 5(1):e8722.
98. Hirano K., Ikegami C., Tsujii K., et al. Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism. Arterioscler Thromb Vasc Biol 2005, 25(11):2422-2427.
99. Robichaud J.C., Francis G.A., Vance D.E. A role for hepatic scavenger receptor class B, type I in decreasing high density lipoprotein levels in mice that lack phosphatidylethanolamine N-methyltransferase. J Biol Chem 2008, 283(51):35496-35506.
100. Diekman M.J., Anghelescu N., Endert E., Bakker O., Wiersinga W.M. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. J Clin Endocrinol Metab 2000, 85(5):1857-1862.
101. Rudling M., Angelin B. Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo. J Clin Invest 1993, 91(6):2796-2805.
102. Guettet C., Rostaqui N., Mathe D., Lecuyer B., Navarro N., Jacotot B. Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol-fed rats. Lipids 1991, 26(6):451-458.
103. Yamamoto A. A uniqe antilipidemic drug-probucol. J Atheroscler Thromb 2008, 15(6):304-305.
104. Hong S.C., Zhao S.P., Wu Z.H. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits. Int J Cardiol 2007, 115(1):29-35.
105. Kocher O., Yesilaltay A., Cirovic C., Pal R., Rigotti A., Krieger M. Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J Biol Chem 2003, 278(52):52820-52825.
106. Silver D.L. A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver. J Biol Chem 2002, 277(37):34042-34047.
107. Silver D.L., Wang N., Vogel S. Identification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levels. J Biol Chem 2003, 278(31):28528-28532.
108. Yesilaltay A., Kocher O., Pal R., et al. PDZK1 is required for maintaining hepatic scavenger receptor, class B, type I (SR-BI) steady state levels but not its surface localization or function. J Biol Chem 2006, 281(39):28975-28980.
109. Fenske S.A., Yesilaltay A., Pal R., et al. Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization. J Biol Chem 2008, 283(32):22097-22104.
110. Fenske S.A., Yesilaltay A., Pal R., et al. Normal hepatic cell-surface localization of the high-density lipoprotein receptor, SR-BI, depends on all four PDZ domains of PDZK1. J Biol Chem 2009, 284(9):5797-5806.
111. Williams D.L., Connelly M.A., Temel R.E., et al. Scavenger receptor BI and cholesterol trafficking. Curr Opin Lipidol 1999, 10(4):329-339.
112. Rinninger F., Brundert M., Jackle S., et al. Selective uptake of high-density lipoprotein-associated cholesteryl esters by human hepatocytes in primary culture. Hepatology 1994, 19(5):1100-1114.
113. Calvo D., Vega M.A. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 1993, 268(25):18929-18935.
114. Acton S., Osgood D., Donoghue M., et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999, 19(7):1734-1743.
115. Hsu L.A., Ko Y.L., Wu S., et al. Association between a novel 11-base pair deletion mutation in the promoter region of the scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese. Arterioscler Thromb Vasc Biol 2003, 23(10):1869-1874.
116. West M., Greason E., Kolmakova A., et al. Scavenger receptor class B type I protein as an independent predictor of high-density lipoprotein cholesterol levels in subjects with hyperalphalipoproteinemia. J Clin Endocrinol Metab 2009, 94(4):1451-1457.
117. Vergeer M., Korporaal S.J., Franssen R., et al. Genetic variant of the scavenger receptor BI in humans. N Engl J Med 2011, 364(2):136-145.
118. Yang Y., Zhang Z., Jiang W., et al. Identification of novel human high-density lipoprotein receptor up-regulators using a cell-based high-throughput screening assay. J Biomol Screen 2007, 12(2):211-219.
119. Kitayama K., Nishizawa T., Abe K., et al. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice. J Pharm Pharmacol 2006, 58(12):1629-1638.
120. Barter P.J., Brewer H.B., Chapman M.J., Hennekens C.H., Rader D.J., Tall A.R. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23(2):160-167.